Estromend
Estromend, licence 80040917: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Douglas Laboratories Canada
- NPN or DIN-HM
- 80040917
- Status
- Active licence
- Licence date
- 15 March 2013
- Revision date
- Not provided
- Form
- Capsule végétale
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Humulus lupulus Source : Strobile Extract Extraction ratio : 10:1 Dry plant equivalent : 750 mg | 75.0 mg | Not calculated |
| Bacopa monnieri Source : Aerial parts extract Potency : 20.0 % bacosides | 84.0 mg | Not calculated |
| Centella asiatica Source : Extrait de Feuille Extraction ratio : 8:1 Dry plant equivalent : 672 mg Potency : 10.0 % asiaticosides | 84.0 mg | Not calculated |
| Angelica sinensis Source : Extrait de racine Extraction ratio : 4:1 Dry plant equivalent : 336 mg Potency : 1.0 % ligustilide | 84.0 mg | Not calculated |
Non-medicinal ingredients
Silice, Stéarate de magnésium, cellulose, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Vcapsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help relieve muscle and joint pain associated with rheumatic conditions such as rheumatoid arthritis, osteoarthritis and/or fibrositis, and of pain associated with neuralgia such as sciatica. Used in Herbal Medicine to help ease nervous tension. Used in Herbal Medicine to help relieve the pain associated with menstruation, premenstrual symptoms, and to relieve symptoms associated with menopause. Hops is traditionally used in Herbal medicine as a sedative and/or calmative to help relieve nervousness and as a sleep aid. Hops is traditionally used in Herbal medicine as an aromatic bitter to aid digestion and to increase appetite as a stomachic.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80040917
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.